Effects of STI571 on acute myelogenous leukemia (AML) cells in vitro.

被引：0
|
作者：
Scappini, B [1 ]
Onida, F [1 ]
Kantarjian, H [1 ]
Li, D [1 ]
Keating, MJ [1 ]
Beran, M [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
492
引用
收藏
页码：114A / 115A
页数：2
相关论文
共 50 条
  • [31] Molecular and cytogenetic changes in STI571 (Gleevec) treated acute lymphoblastic Ph plus leukemia
    Kusec, R
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 93 - 93
  • [32] Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia
    Hofmann, WK
    Komor, M
    Hoelzer, D
    Ottmann, OG
    LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 655 - 660
  • [33] Imatinib mesylate (STI571) considerably affects normal human bone marrow stromal cell growth in vitro.
    Melzer, D
    Neumann, U
    Ebell, W
    Seeger, K
    Neuhaus, P
    Gaedicke, G
    Brummendorf, TH
    Scheding, S
    BLOOD, 2004, 104 (11) : 641A - 641A
  • [34] Establishment of a murine model for therapy-treated chronic myelogenous leukemia using the tyrosine kinase inhibitor STI571
    Wolff, NC
    Ilaria, RL
    BLOOD, 2001, 98 (09) : 2808 - 2816
  • [35] Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis
    Beham-Schmid, C
    Apfelbeck, U
    Sill, H
    Tsybrovsky, O
    Höfler, G
    Haas, OA
    Linkesch, W
    BLOOD, 2002, 99 (01) : 381 - 383
  • [36] STI571: a gene product-targeted therapy for leukemia.
    Mauro M.J.
    Druker B.J.
    Current Oncology Reports, 2001, 3 (3) : 223 - 227
  • [37] Restoration of sensitivity to STI571 in ST1571-resistant chronic myeloid leukemia cells
    Tipping, AJ
    Mahon, FX
    Lagarde, V
    Goldman, JM
    Melo, JV
    BLOOD, 2001, 98 (13) : 3864 - 3867
  • [38] Troxatyl and STI571 combination therapy for chronic myeloid leukemia: Preclinical in vitro and in vivo evaluation.
    Orsolic, N
    Giles, F
    Beran, M
    Cortes, J
    Albitar, M
    Kantarjian, H
    Verstovsek, S
    BLOOD, 2002, 100 (11) : 786A - 786A
  • [39] The Effects of Genistein and STI571 (Imatinib) on Signal Protein Levels Affecting Chronic Myeloid Leukemia
    Armutcuoglu, Nur Erden
    Kasap, Yesim Korkmaz
    Yurtcu, Erkan
    GAZI MEDICAL JOURNAL, 2018, 29 (03): : 187 - 190
  • [40] Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro
    Graham, SM
    Jorgensen, HG
    Allan, E
    Pearson, C
    Alcorn, MJ
    Richmond, L
    Holyoake, TL
    BLOOD, 2002, 99 (01) : 319 - 325
12345